Malaria Treatment Global Market Report 2024

Description

Malaria treatment encompasses the medical interventions and procedures aimed at diagnosing, managing, and curing malaria, a potentially life-threatening mosquito-borne disease caused by the Plasmodium parasite.

The primary components of malaria treatment include prescription medications, vaccines, diagnostic tests, and other therapeutic approaches. Prescription medications are pharmaceuticals that require a valid prescription from a healthcare professional. In the context of malaria treatment, these drugs are essential for providing targeted and regulated therapy to combat the infection. They can be administered through oral, parenteral, and intravenous routes and are distributed through various channels such as direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. These channels serve hospitals, specialty clinics, home care settings, and other end users, ensuring a comprehensive reach for malaria treatment options.

The malaria treatment market research report is one of a series of new reports from The Business Research Company that provides malaria treatment market statistics, including malaria treatment industry global market size, regional shares, competitors with a malaria treatment market share, detailed malaria treatment market segments, market trends and opportunities, and any further data you may need to thrive in the malaria treatment industry. This malaria treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The malaria treatment market size has grown strongly in recent years. It will grow from $1.49 billion in 2023 to $1.57 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth observed in the historic period can be attributed to several key factors. These include the discovery of effective drugs for treating malaria, concerted efforts in vector control, global health initiatives aimed at combating malaria, advancements in scientific research contributing to better understanding and treatment options, and the development of health infrastructure to support malaria prevention and treatment efforts. Collectively, these factors played a crucial role in fostering growth and progress in addressing the challenges posed by malaria during the historical period.

The malaria treatment market size is expected to see strong growth in the next few years. It will grow to $1.94 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The projected expansion during the forecast period can be ascribed to factors such as the monitoring of drug resistance, the impact of climate change, the adoption of precision medicine and genomic approaches, reforms in healthcare financing, and the integration of digital health solutions. Key trends anticipated during the forecast period encompass enhancements in epidemiological surveillance, the integration of alternative medicine, advancements in malaria vaccine development, the implementation of data-driven treatment programs, and the initiation of education and training initiatives.

The anticipated surge in the prevalence of malaria is poised to drive the expansion of the malaria treatment market in the coming years. Malaria, a potentially life-threatening mosquito-borne ailment caused by the Plasmodium parasite, manifests with recurrent fever and flu-such as symptoms. This upswing in malaria cases is attributable to factors such as poverty, limited access to healthcare services, climate change, absence of robust malaria control measures, and emerging drug resistance. Malaria treatment plays a pivotal role in effectively managing and curing infections caused by the Plasmodium parasite.

The growth of the malaria treatment market is bolstered by the escalation in healthcare spending. Healthcare spending, denoting the overall financial resources allocated to the healthcare sector within a specific region, country, or organization, is instrumental in efficiently managing and preventing the proliferation of the disease. This involves ensuring access to timely diagnosis, antimalarial medications, and preventive measures. As an illustrative example, a report from the American Medical Association in March 2023 revealed a 2.7% increase in health spending in the United States in 2021, reaching $4.3 trillion, equivalent to $12,914 per capita. Consequently, the upsurge in healthcare spending is a key driver fueling the growth of the malaria treatment market in the foreseeable future.

The malaria treatment market is witnessing a notable trend with the emergence of novel diagnostic technologies, a development gaining traction among companies in the industry. To maintain their competitive edge, companies in the malaria treatment market are increasingly embracing innovative diagnostic malaria detection technologies. An example is Sysmex America Inc., a US-based developer and manufacturer of automated diagnostic technology, which introduced the XN-30 in October 2021. This automated hematology analyzer incorporates features such as a violet laser, specialized reagents, and advanced algorithms, enabling the differentiation of malarial strains such as P. falciparum and non-falciparum species, along with understanding their life cycle staging. Such advancements in detection contribute to the effective management of malaria treatment and patient recovery.

Major players in the malaria treatment market are adopting a strategic partnership approach to expedite the elimination of relapsing P. vivax malaria. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. An illustrative example is the collaboration between PATH, a US-based nonprofit global health organization, and Medicines for Malaria Venture (MMV), a Switzerland-based foundation specializing in antimalarial drug research and development. This partnership aims to advance the development of quality-assured, child-friendly treatments for relapse prevention, generate evidence to support malaria-endemic countries in developing and implementing new strategies for P. vivax malaria elimination, and promote the development and availability of quality-assured medicines and diagnostics for P. vivax.

In November 2022, Novartis AG, a Switzerland-based pharmaceutical and healthcare company, joined forces with Medicines for Malaria Venture to conduct phase III clinical trials for a novel ganaplacide and lumefantrine-SDF medication combination targeting malaria in both adults and children. Medicines for Malaria Venture (MMV), as a Switzerland-based non-profit organization focused on antimalarial drug research and development, underscores the collaborative efforts within the industry to advance malaria treatment solutions.

Major companies operating in the malaria treatment market report are Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, GlaxoSmithKline PLC., Takeda Pharmaceutical Company Limited, Sumitomo Chemical Co. Ltd., Viatris Inc., Mylan N.V., Sandoz International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Zydus Lifesciences Ltd., Medicines Sans Frontieres (Doctors Without Borders), Strides Pharma Science Limited, Swiss Tropical and Public Health Institute (Swiss TPH), Aprecia Pharmaceuticals LLC, AdvaCare Pharma USA LLC, Medicines for Malaria Venture (MMV), VLP Therapeutics LLC, Actiza Pharmaceutical Private Limited

Middle East and Africa was the largest region in the malaria treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the malaria treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The malaria treatment market consists of sales of antimicrobial medications, antimalarial drugs, antipyretics, intravenous fluids, and supportive care products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Malaria Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on malaria treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for malaria treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The malaria treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Treatment: Prescription Medications; Vaccines; Diagnostic Tests; Other Treatments
2) By Route of Administration: Oral; Parenteral; Intravenous
3) By Distribution Channel: Direct Tender; Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
4) By End User: Hospitals; Specialty Clinics; Homecare; Other End Users
Companies Mentioned: Pfizer Inc.; Merck & Co.; Johnson & Johnson; Roche Holding AG; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13734

1. Executive Summary

2. Malaria Treatment Market Characteristics

3. Malaria Treatment Market Trends And Strategies

4. Malaria Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Malaria Treatment Market Size and Growth

5.1. Global Malaria Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Malaria Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Malaria Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Malaria Treatment Market Segmentation

6.1. Global Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Prescription Medications
Vaccines
Diagnostic Tests
Other Treatments
6.2. Global Malaria Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
Intravenous
6.3. Global Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Direct Tender
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.4. Global Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics
Homecare
Other End Users

7. Malaria Treatment Market Regional And Country Analysis

7.1. Global Malaria Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Malaria Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Malaria Treatment Market

8.1. Asia-Pacific Malaria Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Malaria Treatment Market

9.1. China Malaria Treatment Market Overview
9.2. China Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Malaria Treatment Market

10.1. India Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Malaria Treatment Market

11.1. Japan Malaria Treatment Market Overview
11.2. Japan Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Malaria Treatment Market

12.1. Australia Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Malaria Treatment Market

13.1. Indonesia Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Malaria Treatment Market

14.1. South Korea Malaria Treatment Market Overview
14.2. South Korea Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Malaria Treatment Market

15.1. Western Europe Malaria Treatment Market Overview
15.2. Western Europe Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Malaria Treatment Market

16.1. UK Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Malaria Treatment Market

17.1. Germany Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Malaria Treatment Market

18.1. France Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Malaria Treatment Market

19.1. Italy Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Malaria Treatment Market

20.1. Spain Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Malaria Treatment Market

21.1. Eastern Europe Malaria Treatment Market Overview
21.2. Eastern Europe Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Malaria Treatment Market

22.1. Russia Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Malaria Treatment Market

23.1. North America Malaria Treatment Market Overview
23.2. North America Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Malaria Treatment Market

24.1. USA Malaria Treatment Market Overview
24.2. USA Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Malaria Treatment Market

25.1. Canada Malaria Treatment Market Overview
25.2. Canada Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Malaria Treatment Market

26.1. South America Malaria Treatment Market Overview
26.2. South America Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Malaria Treatment Market

27.1. Brazil Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Malaria Treatment Market

28.1. Middle East Malaria Treatment Market Overview
28.2. Middle East Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Malaria Treatment Market

29.1. Africa Malaria Treatment Market Overview
29.2. Africa Malaria Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Malaria Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Malaria Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Malaria Treatment Market Competitive Landscape And Company Profiles

30.1. Malaria Treatment Market Competitive Landscape
30.2. Malaria Treatment Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Johnson & Johnson
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Roche Holding AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Malaria Treatment Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Sanofi SA
31.3. AstraZeneca Plc
31.4. GlaxoSmithKline PLC.
31.5. Takeda Pharmaceutical Company Limited
31.6. Sumitomo Chemical Co. Ltd.
31.7. Viatris Inc.
31.8. Mylan N.V.
31.9. Sandoz International GmbH
31.10. Eisai Co. Ltd.
31.11. Sun Pharmaceutical Industries Ltd.
31.12. Serum Institute of India
31.13. Cipla Ltd.
31.14. Amneal Pharmaceuticals LLC
31.15. Lupin Ltd.

32. Global Malaria Treatment Market Competitive Benchmarking

33. Global Malaria Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Malaria Treatment Market

35. Malaria Treatment Market Future Outlook and Potential Analysis

35.1 Malaria Treatment Market In 2028 - Countries Offering Most New Opportunities
35.2 Malaria Treatment Market In 2028 - Segments Offering Most New Opportunities
35.3 Malaria Treatment Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer